SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-15-007629
Filing Date
2015-04-17
Accepted
2015-04-17 17:26:32
Documents
5
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A pdli20150417_10ka.htm 10-K/A 111388
2 EXHIBIT 10.64 ex10-64.htm EX-10.64 61915
3 EXHIBIT 31.1 ex31-1.htm EX-31.1 4812
4 EXHIBIT 31.2 ex31-2.htm EX-31.2 4813
5 img.jpg GRAPHIC 5093
  Complete submission text file 0001437749-15-007629.txt   191160
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-19756 | Film No.: 15779077
SIC: 2836 Biological Products, (No Diagnostic Substances)